table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Passive Transdermal Drug Delivery Market Size Analysis from 2023 to 2028
1.5.1 Global Passive Transdermal Drug Delivery Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Passive Transdermal Drug Delivery Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Passive Transdermal Drug Delivery Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Passive Transdermal Drug Delivery Industry Impact
Chapter 2 Global Passive Transdermal Drug Delivery Competition by Types, Applications, and Top Regions and Countries
2.1 Global Passive Transdermal Drug Delivery (Volume and Value) by Type
2.1.1 Global Passive Transdermal Drug Delivery Consumption and Market Share by Type (2017-2022)
2.1.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2017-2022)
2.2 Global Passive Transdermal Drug Delivery (Volume and Value) by Application
2.2.1 Global Passive Transdermal Drug Delivery Consumption and Market Share by Application (2017-2022)
2.2.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Application (2017-2022)
2.3 Global Passive Transdermal Drug Delivery (Volume and Value) by Regions
2.3.1 Global Passive Transdermal Drug Delivery Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Passive Transdermal Drug Delivery Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Passive Transdermal Drug Delivery Consumption by Regions (2017-2022)
4.2 North America Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.10 South America Passive Transdermal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Passive Transdermal Drug Delivery Market Analysis
5.1 North America Passive Transdermal Drug Delivery Consumption and Value Analysis
5.1.1 North America Passive Transdermal Drug Delivery Market Under COVID-19
5.2 North America Passive Transdermal Drug Delivery Consumption Volume by Types
5.3 North America Passive Transdermal Drug Delivery Consumption Structure by Application
5.4 North America Passive Transdermal Drug Delivery Consumption by Top Countries
5.4.1 United States Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
5.4.2 Canada Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
5.4.3 Mexico Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 6 East Asia Passive Transdermal Drug Delivery Market Analysis
6.1 East Asia Passive Transdermal Drug Delivery Consumption and Value Analysis
6.1.1 East Asia Passive Transdermal Drug Delivery Market Under COVID-19
6.2 East Asia Passive Transdermal Drug Delivery Consumption Volume by Types
6.3 East Asia Passive Transdermal Drug Delivery Consumption Structure by Application
6.4 East Asia Passive Transdermal Drug Delivery Consumption by Top Countries
6.4.1 China Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
6.4.2 Japan Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
6.4.3 South Korea Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 7 Europe Passive Transdermal Drug Delivery Market Analysis
7.1 Europe Passive Transdermal Drug Delivery Consumption and Value Analysis
7.1.1 Europe Passive Transdermal Drug Delivery Market Under COVID-19
7.2 Europe Passive Transdermal Drug Delivery Consumption Volume by Types
7.3 Europe Passive Transdermal Drug Delivery Consumption Structure by Application
7.4 Europe Passive Transdermal Drug Delivery Consumption by Top Countries
7.4.1 Germany Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.2 UK Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.3 France Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.4 Italy Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.5 Russia Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.6 Spain Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.7 Netherlands Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.8 Switzerland Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
7.4.9 Poland Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 8 South Asia Passive Transdermal Drug Delivery Market Analysis
8.1 South Asia Passive Transdermal Drug Delivery Consumption and Value Analysis
8.1.1 South Asia Passive Transdermal Drug Delivery Market Under COVID-19
8.2 South Asia Passive Transdermal Drug Delivery Consumption Volume by Types
8.3 South Asia Passive Transdermal Drug Delivery Consumption Structure by Application
8.4 South Asia Passive Transdermal Drug Delivery Consumption by Top Countries
8.4.1 India Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
8.4.2 Pakistan Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Passive Transdermal Drug Delivery Market Analysis
9.1 Southeast Asia Passive Transdermal Drug Delivery Consumption and Value Analysis
9.1.1 Southeast Asia Passive Transdermal Drug Delivery Market Under COVID-19
9.2 Southeast Asia Passive Transdermal Drug Delivery Consumption Volume by Types
9.3 Southeast Asia Passive Transdermal Drug Delivery Consumption Structure by Application
9.4 Southeast Asia Passive Transdermal Drug Delivery Consumption by Top Countries
9.4.1 Indonesia Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
9.4.2 Thailand Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
9.4.3 Singapore Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
9.4.4 Malaysia Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
9.4.5 Philippines Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
9.4.6 Vietnam Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
9.4.7 Myanmar Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 10 Middle East Passive Transdermal Drug Delivery Market Analysis
10.1 Middle East Passive Transdermal Drug Delivery Consumption and Value Analysis
10.1.1 Middle East Passive Transdermal Drug Delivery Market Under COVID-19
10.2 Middle East Passive Transdermal Drug Delivery Consumption Volume by Types
10.3 Middle East Passive Transdermal Drug Delivery Consumption Structure by Application
10.4 Middle East Passive Transdermal Drug Delivery Consumption by Top Countries
10.4.1 Turkey Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.3 Iran Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.5 Israel Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.6 Iraq Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.7 Qatar Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.8 Kuwait Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
10.4.9 Oman Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 11 Africa Passive Transdermal Drug Delivery Market Analysis
11.1 Africa Passive Transdermal Drug Delivery Consumption and Value Analysis
11.1.1 Africa Passive Transdermal Drug Delivery Market Under COVID-19
11.2 Africa Passive Transdermal Drug Delivery Consumption Volume by Types
11.3 Africa Passive Transdermal Drug Delivery Consumption Structure by Application
11.4 Africa Passive Transdermal Drug Delivery Consumption by Top Countries
11.4.1 Nigeria Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
11.4.2 South Africa Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
11.4.3 Egypt Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
11.4.4 Algeria Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
11.4.5 Morocco Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 12 Oceania Passive Transdermal Drug Delivery Market Analysis
12.1 Oceania Passive Transdermal Drug Delivery Consumption and Value Analysis
12.2 Oceania Passive Transdermal Drug Delivery Consumption Volume by Types
12.3 Oceania Passive Transdermal Drug Delivery Consumption Structure by Application
12.4 Oceania Passive Transdermal Drug Delivery Consumption by Top Countries
12.4.1 Australia Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
12.4.2 New Zealand Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 13 South America Passive Transdermal Drug Delivery Market Analysis
13.1 South America Passive Transdermal Drug Delivery Consumption and Value Analysis
13.1.1 South America Passive Transdermal Drug Delivery Market Under COVID-19
13.2 South America Passive Transdermal Drug Delivery Consumption Volume by Types
13.3 South America Passive Transdermal Drug Delivery Consumption Structure by Application
13.4 South America Passive Transdermal Drug Delivery Consumption Volume by Major Countries
13.4.1 Brazil Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
13.4.2 Argentina Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
13.4.3 Columbia Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
13.4.4 Chile Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
13.4.5 Venezuela Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
13.4.6 Peru Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
13.4.8 Ecuador Passive Transdermal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Passive Transdermal Drug Delivery Business
14.1 3M
14.1.1 3M Company Profile
14.1.2 3M Passive Transdermal Drug Delivery Product Specification
14.1.3 3M Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Actavis, Inc.
14.2.1 Actavis, Inc. Company Profile
14.2.2 Actavis, Inc. Passive Transdermal Drug Delivery Product Specification
14.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bayer AG
14.3.1 Bayer AG Company Profile
14.3.2 Bayer AG Passive Transdermal Drug Delivery Product Specification
14.3.3 Bayer AG Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Boehringer Ingelheim GmbH
14.4.1 Boehringer Ingelheim GmbH Company Profile
14.4.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Specification
14.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Corium International, Inc.
14.5.1 Corium International, Inc. Company Profile
14.5.2 Corium International, Inc. Passive Transdermal Drug Delivery Product Specification
14.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Echo Therapeutics, Inc.
14.6.1 Echo Therapeutics, Inc. Company Profile
14.6.2 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Specification
14.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 GlaxoSmithKline plc
14.7.1 GlaxoSmithKline plc Company Profile
14.7.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Specification
14.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
14.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Profile
14.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Specification
14.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Mylan N.V.
14.9.1 Mylan N.V. Company Profile
14.9.2 Mylan N.V. Passive Transdermal Drug Delivery Product Specification
14.9.3 Mylan N.V. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Novartis AG
14.10.1 Novartis AG Company Profile
14.10.2 Novartis AG Passive Transdermal Drug Delivery Product Specification
14.10.3 Novartis AG Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Noven Pharmaceuticals, Inc.
14.11.1 Noven Pharmaceuticals, Inc. Company Profile
14.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Specification
14.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Transdermal Corp.
14.12.1 Transdermal Corp. Company Profile
14.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Product Specification
14.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Passive Transdermal Drug Delivery Market Forecast (2023-2028)
15.1 Global Passive Transdermal Drug Delivery Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Passive Transdermal Drug Delivery Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Passive Transdermal Drug Delivery Value and Growth Rate Forecast (2023-2028)
15.2 Global Passive Transdermal Drug Delivery Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Passive Transdermal Drug Delivery Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Passive Transdermal Drug Delivery Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Passive Transdermal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Passive Transdermal Drug Delivery Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Passive Transdermal Drug Delivery Consumption Forecast by Type (2023-2028)
15.3.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2023-2028)
15.3.3 Global Passive Transdermal Drug Delivery Price Forecast by Type (2023-2028)
15.4 Global Passive Transdermal Drug Delivery Consumption Volume Forecast by Application (2023-2028)
15.5 Passive Transdermal Drug Delivery Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
